Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-20-071718
Filing Date
2020-03-12
Accepted
2020-03-12 17:16:03
Documents
5
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d859387d10ka.htm 10-K/A 424244
2 EX-23.1 d859387dex231.htm EX-23.1 1688
3 EX-31.1 d859387dex311.htm EX-31.1 10872
4 EX-31.2 d859387dex312.htm EX-31.2 11003
5 EX-32.1 d859387dex321.htm EX-32.1 5464
  Complete submission text file 0001193125-20-071718.txt   454334
Mailing Address 21 ERIE STREET CAMBRIDGE MA 02139
Business Address 21 ERIE STREET CAMBRIDGE MA 02139 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38327 | Film No.: 20709775
SIC: 2834 Pharmaceutical Preparations